e-learning
resources
Stockholm 2007
Monday 17.09.2007
Pulmonary hypertension: diagnosis and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Can brain natriuretic peptide (BNP) be a predictor for pulmonary arterial hypertension?
G. Okumus, E. Kiyan, A. K. Bilge, Z. Kaya, F. Comce, M. Bolayir, G. Kuran, A. Kiyan, L. Tabak, O. Arseven (Istanbul, Bolu, Turkey)
Source:
Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment
Session:
Pulmonary hypertension: diagnosis and treatment
Session type:
Oral Presentation
Number:
1804
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Okumus, E. Kiyan, A. K. Bilge, Z. Kaya, F. Comce, M. Bolayir, G. Kuran, A. Kiyan, L. Tabak, O. Arseven (Istanbul, Bolu, Turkey). Can brain natriuretic peptide (BNP) be a predictor for pulmonary arterial hypertension?. Eur Respir J 2007; 30: Suppl. 51, 1804
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
N-terminal-pro-brain natriuretic peptide as a haemodynamic marker in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2005; 25: 509-513
Year: 2005
N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism
Source: Eur Respir J 2003 Oct 01;22(4):649-653
Year: 2003
Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension
Source: Eur Respir J 2010; 35: 95-104
Year: 2010
Identification of left ventricular systolic dysfunction or pulmonary hypertension in patients with asthma or chronic obstructive pulmonary disease by N-terminal pro-brain natriuretic peptide
Source: Annual Congress 2007 - New insight into the pathophysiology of asthma
Year: 2007
The relationship between pro-BNP(brain natriuretic peptide), c-reactive protein(CRP) and right ventricular dysfunction in pulmonary embolism
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009
A point-of-care brain natriuretic peptide assay in the risk stratification and management of patients with pulmonary arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 48s
Year: 2006
N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pulmonary hypertension and renal insufficiency
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
The diagnostic value of N-terminal pro-C-type natriuretic peptide in COPD patients with pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 111s
Year: 2004
Brain natriuretic peptide (BNP) and right ventricular dysfunction predict survival in interstitial lung disease (ILD)
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008
Brain natriuretic peptide in patients with acute pulmonary embolism
Source: Eur Respir J 2005; 26: Suppl. 49, 270s
Year: 2005
Atrial natriuretic peptide as a serum marker of right atrial enlargement and function in pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
The prognostic value of repeated measurements of N-terminal pro-B-type natriuretic peptide in patients with pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010
Effect of noninvasive ventilation (NIV) on left ventricular (LV) function, B-type natriuretic peptide (BNP) and markers of systemic inflammation in patients with refractory heart failure
Source: Eur Respir J 2006; 28: Suppl. 50, 188s
Year: 2006
NT-proBNP reflects right ventricular structure and function in pulmonary hypertension
Source: Eur Respir J 2006; 28: 1190-1194
Year: 2006
Correlation of levels of N-terminal pro-B-type natriuretic peptide with localization of thrombus in acute pulmonary embolism
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011
Biomarkers in pulmonary hypertension
Source: Eur Respir J 2008; 32: 503-512
Year: 2008
Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension
Source: Eur Respir J 2010; 35: 1286-1293
Year: 2010
Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism
Source: Eur Respir J 2014; 43: 1669-1677
Year: 2014
Role of B-type brain natriuretic peptide in the development of fluid retention and detection of right ventricular failure in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 305s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept